Cite
MLA Citation
M.S. Davids et al.. “UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL.” Hematological oncology, vol. 35, n.d., pp. 54–55. http://access.bl.uk/ark:/81055/vdc_100047460085.0x00001f